Onc Now: Microbes, AI, and the Future of Precision Oncology - European Medical Journal

This site is intended for healthcare professionals

Onc Now: Microbes, AI, and the Future of Precision Oncology

Oncology

Onc Now 

In this episode of Onc Now, Miguel Reis Ferreira explores the evolving relationship between the microbiome and cancer, from treatment-related toxicity and tumour-associated bacteria to the potential of AI and microbiome-based biomarkers in precision oncology.

Apple | Spotify | Amazon Music | Youtube

 

Speaker bio: 

Miguel Reis FerreiraMiguel Reis Ferreira is a Senior Clinical Lecturer at King’s College London, and a Consultant Clinical Oncologist at Guy’s and St Thomas’ NHS Foundation Trust in London, UK. His research spans oncology, microbiology, and AI, with a particular focus on understanding the influence of the microbiome, and he has pioneered research into the role of tumour-associated bacteria in cancer.

 

 

Timestamps:

00:00 – Introduction

01:28 – Clinical and Research Interests

06:52 – Microbiome and Treatment Toxicity

10:12 – Personalising Radiotherapy with Biomarkers

12:40 – Bacteria Within Tumours

18:02 – The Future of Oncomicrobiology

19:17 – AI in Radiation Oncology

21:48 – Unanswered Questions in Microbiome Research

23:35 – Three Wishes for Oncology

 

Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.

Rate this content's potential impact on patient outcomes

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this content.